The aim of the study was to investigate urinary and serum tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) as potential biomarkers in a longitudinal cohort of patients with ANCA-associated vasculitis (AAV). The gene discussed is TNF; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.